-+ 0.00%
-+ 0.00%
-+ 0.00%

FDA Accepts BioCardia's Helix Catheter Pre-Submission Package

PUBT·10/19/2026 13:27:54
Listen to the news
FDA Accepts BioCardia's Helix Catheter Pre-Submission Package
  • FDA accepted BioCardia's De Novo pre-submission package seeking marketing clearance for its Helix catheter for therapeutic and diagnostic agent delivery.
  • Substantive FDA review, written feedback and a meeting to discuss De Novo clearance are expected this quarter.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioCardia Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-032887), on October 19, 2026, and is solely responsible for the information contained therein.